•
Sep 30, 2022

iTeos Therapeutics Q3 2022 Earnings Report

Total Revenue
$19.5M
Previous year: $104M
-81.3%
EPS
$0.03
Previous year: $1.86
-98.4%
Gross Profit
$19.3M
Previous year: $104M
-81.5%
Cash and Equivalents
$752M
Previous year: $900M
-16.4%
Free Cash Flow
-$29.8M
Previous year: $604M
-104.9%
Total Assets
$778M
Previous year: $922M
-15.7%

iTeos Therapeutics

iTeos Therapeutics